Indicated for the treatment of mild, moderate and severe infections in adults (aged 18 years and over) caused by susceptible strains of bacteria. The specification is 100 ml containing 0.5 g levofloxacin and 0.9 g sodium chloride, approval No. H20223903. It is an injection manufactured on a contract basis using the company own large-volume injection (including blood preservation solution) production line.
